REG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - TAKEDA PHARMACEUTICAL

Takeda Pharmaceutical CoAnnouncement

31/12/2018 10:20

RNS Number : 8036L
Morgan Stanley
31 December 2018
 


 
 FORM 8.5 (EPT/NON-RI)
 
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
 
1.         KEY INFORMATION
 



(a) Name of exempt principal trader:


Morgan Stanley MUFG Securities Co., Ltd.




(b) Name of offeror/offeree in relation to whose relevant securities this form relates:
     Use a separate form for each offeror/offeree


Takeda Pharmaceutical Company Limited




(c) Name of the party to the offer with which exempt principal trader is connected:


Shire plc




(d) Date position held/dealing undertaken
     For an opening position disclosure, state the latest practicable date prior to the disclosure


28 DECEMBER 2018




(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?
     If it is a cash offer or possible cash offer, state "N/A"


Yes - Shire plc
 



 
 
2.         POSITIONS OF THE EXEMPT PRINCIPAL TRADER
 
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
 
 (a)       Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
 



 Class of relevant security:


Ordinary
 








 Interests


Short positions
 




 Number


  %


Number


  %




 (1) Relevant securities owned  and/or controlled:


10,379,845


1.32


41,102,197


5.24




 (2) Cash-settled derivatives:


34,148,156


4.35


3,312,659


0.42
 




 (3) Stock-settled derivatives (including options) and  agreements to purchase/sell:


315,000


0.04


315,000


0.04




  TOTAL:


44,843,001


5.72


44,729,856


5.70
 



 
 
All interests and all short positions should be disclosed.
 
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
 
(b)        Rights to subscribe for new securities (including directors' and other employee options)
 



 Class of relevant security in relation to which subscription right exists:


 N/A




 Details, including nature of the rights concerned and relevant percentages:


 N/A



 
 
3.         DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
 
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
 
The currency of all prices and other monetary amounts should be stated.
 
 
(a)        Purchases and sales
 



 Class of
relevant
security


 Purchases/
sales


 Total number
of securities


 Highest price
per unit paid/received


 Lowest price
per unit paid/received




 Ordinary


 PURCHASES


 2,205,282


 3,773.0000 JPY


 3,692.0000 JPY
 




 Ordinary


 SALES


 1,978,682


 3,768.0000 JPY


 3,697.0000 JPY
 



 
(b)        Cash-settled derivative transactions
 



  Class of
relevant
security


 Product description
 e.g. CFD


 Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position


 Number of reference securities


 Price per
unit




Ordinary


CFD


SHORT


1500


3727.0000 JPY




Ordinary


CFD


SHORT


1500


3728.0666 JPY




Ordinary


CFD


LONG


2100


3705.0000 JPY




Ordinary


CFD


LONG


14200


3721.4718 JPY




Ordinary


CFD


SHORT


600


3792.0000 JPY




Ordinary


CFD


LONG


283800


3784.9379 JPY




Ordinary


CFD


SHORT


522200


3754.8651 JPY




Ordinary


CFD


LONG


37400


3758.3262 JPY




Ordinary


CFD


LONG


1100


3723.4166 JPY




Ordinary


CFD


SHORT


1100


3728.2727 JPY




Ordinary


CFD


SHORT


4600


3705.8043 JPY




Ordinary


CFD


LONG


2100


3716.5238 JPY




Ordinary


CFD


LONG


17800


3727.2800 JPY




Ordinary


CFD


SHORT


22600


3708.2977 JPY




Ordinary


CFD


SHORT


500


3706.2000 JPY




Ordinary


CFD


SHORT


30000


3717.3633 JPY




Ordinary


CFD


SHORT


38600


3704.3963 JPY




Ordinary


CFD


LONG


100


3723.4166 JPY




Ordinary


CFD


LONG


50000


3760.0000 JPY



 
(c)        Stock-settled derivative transactions (including options)
 
(i)         Writing, selling, purchasing or varying
 



 Class
of
relevant
security


 Product description  e.g. call option


 Writing, purchasing,
selling,
varying etc.


 Number
of securities to which option relates


 Exercise price
per unit


 Type
e.g. American, European etc.


 Expiry date


 Option money paid/ received per unit
 




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A  
 



 
(ii)        Exercise
 



 Class of
relevant
security


 Product description
e.g. call option


 Exercising/
exercised
against


 Number of securities


 Exercise price
per unit
 




 N/A


 N/A


 N/A


 N/A


 N/A  
 



 
(d)        Other dealings (including subscribing for new securities)
 



 Class of relevant
security


 Nature of dealing
e.g. subscription, conversion


 Details


 Price per unit (if applicable)




 N/A


 N/A


 N/A


 N/A  
 



 
 
4.         OTHER INFORMATION
 
(a)        Indemnity and other dealing arrangements
 



Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"




 
NONE
 



 
 
 (b)       Agreements, arrangements or understandings relating to options or derivatives
 



Details of any agreement, arrangement or understanding, formal or informal, between
the exempt principal trader making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"




 
NONE
 



 
(c)        Attachments
 



   Is a Supplemental Form 8 (Open Positions) attached?


                 YES  
 



 
 



 Date of disclosure:


 31 DECEMBER 2018
 




 Contact name:


 Craig Horsley
 




 Telephone number:


 +44(141) 245 7736
 



 
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
 
 
 
 
                                                            SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
 
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS,
AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
 
 
1.         KEY INFORMATION
 



Full name of person making disclosure:


Morgan Stanley MUFG Securities Co., Ltd.




Name of offeror/offeree in relation to whose relevant securities the disclosure relates:


Takeda Pharmaceutical Company Limited



 
2.         STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
 



Class of relevant security


Product description e.g. call option


Written or purchased


Number of securities
to which
option or
derivative relates


Exercise
price
per unit


Type
e.g. American,
European
etc


Expiry
date




Ordinary


PUT


PURCHASED


125,000


4507.0000 JPY


European


13/12/2019




Ordinary


CALL


PURCHASED


125,000


4507.0000 JPY


European


13/12/2019




Ordinary


PUT


PURCHASED


60,000


4596.0000 JPY


European


14/06/2019




Ordinary


CALL


PURCHASED


60,000


4596.0000 JPY


European


14/06/2019




Ordinary


PUT


PURCHASED


65,000


4414.0000 JPY


European


14/06/2019




Ordinary


CALL


PURCHASED


65,000


4414.0000 JPY


European


14/06/2019




Ordinary


PUT


PURCHASED


65,000


4414.0000 JPY


European


13/12/2019




Ordinary


CALL


PURCHASED


65,000


4414.0000 JPY


European


13/12/2019



 
 
3.         AGREEMENTS TO PURCHASE OR SELL ETC.
 



Full details should be given so that the nature of the interest or position can be fully understood:




 
 
 
 
 



 
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
 
The currency of all prices and other monetary amounts should be stated.
 
 
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FEOEAEAFDFKPFFF